Circulating Tumor DNA: A Promising Biomarker for Predicting Recurrence in Patients with BRAF-Negative Melanoma.

导出原文传递

翻译打印收藏纠错

作者： Lauren G,Aoude ^[1] ; Sandra,Brosda ^[2] ; Jessica,Ng ^[3] ; James M,Lonie ^[2] ; Clemence J,Belle ^[2] ; Kalpana,Patel ^[2] ; Lambros T,Koufariotis ^[4] ; Scott,Wood ^[4] ; Victoria,Atkinson ^[3] ; B Mark,Smithers ^[5] ; John V,Pearson ^[4] ; Nicola,Waddell ^[4] ; Andrew P,Barbour ^[6] ; Vanessa F,Bonazzi ^[7]

作者单位： Frazer Institute, University of Queensland, Woolloongabba, Queensland. Electronic address: l.aoude@uq.edu.au. ^[1] Frazer Institute, University of Queensland, Woolloongabba, Queensland. ^[2] Queensland Melanoma Project, Princess Alexandra Hospital, Woolloongabba, Queensland. ^[3] QIMR Berghofer Medical Research Institute, Herston, Queensland. ^[4] Queensland Melanoma Project, Princess Alexandra Hospital, Woolloongabba, Queensland; Faculty of Medicine, University of Queensland, Herston, Queensland, Australia. ^[5] Frazer Institute, University of Queensland, Woolloongabba, Queensland; Queensland Melanoma Project, Princess Alexandra Hospital, Woolloongabba, Queensland. ^[6] Frazer Institute, University of Queensland, Woolloongabba, Queensland. Electronic address: v.bonazzi@uq.edu.au. ^[7]

主题词人类(Humans);原癌基因蛋白质B-raf(Proto-Oncogene Proteins B-raf);血管内皮生长因子A(Vascular Endothelial Growth Factor A);黑色素瘤(Melanoma);突变(Mutation)

DOI 10.1016/j.jmoldx.2023.06.014

PMID 37544359

发布时间 2023-09-27

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交